Mutant B-Raf Kinase Inhibitors as Anticancer Agents

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 12, 2016-12 ,pp. : 1558-1575

Bentham Science Publishers

Access to resources Recommend Favorite

CDC25 Inhibitors as Anticancer Agents Are Moving Forward

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 8, 2008-12 ,pp. : 857-862

Bentham Science Publishers

Access to resources Recommend Favorite

1,3,4-oxadiazole-2-thione Derivatives; Novel Approach for Anticancer and Tubulin Polymerization Inhibitory Activities

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 2, 2016-02 ,pp. : 269-9

Bentham Science Publishers

Access to resources Recommend Favorite

A quantitative evaluation of the effects of inhibitors of tubulin assembly on polymerization induced by discodermolide, epothilone B, and paclitaxel

By Dabydeen Donnette   Florence Gordon   Paterson Ian   Hamel Ernest  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 5, 2004-05 ,pp. : 397-403

Springer Publishing Company

Access to resources Recommend Favorite

Advances in the Chemistry and Pharmacology of Ecteinascidins, A Promising New Class of Anticancer Agents

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 1, Iss. 3, 2001-11 ,pp. : 257-276

Bentham Science Publishers

Access to resources Recommend Favorite